Global Pharmaceuticals Market 2022 - Industry Briefing

April 2022 | 47 pages | ID: G1F7F9F4897AEN
Gen Consulting Company

Abstracts

Pharmaceuticals are substances used in the diagnosis, treatment, or prevention of disease and for restoring, correcting, or modifying organic functions. According to latest analysis by Gen Consulting Company, the global pharmaceuticals market was USD 1,345 billion in 2021 and is expected to reach USD 1,855 billion in 2028 and register a CAGR of 4.7% during the forecast period, 2022-2028.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, therapeutic area, and region. The global market data on pharmaceuticals can be segmented by product: biologic drugs, small molecule drugs. According to the research, the small molecule drugs segment had the largest share in the global pharmaceuticals market. Pharmaceuticals market is further segmented by therapeutic area: antidiabetic drugs, antirheumatic drugs, antiviral drugs, dermatological drugs, immunosuppressants, oncology drugs, vaccines, others. Based on region, the pharmaceuticals market is segmented into: North America, Asia Pacific, Europe, Rest of the World (ROW).

The global pharmaceuticals market is highly competitive. Key companies profiled in the report include AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Biogen Inc., Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., Novartis International AG, Pfizer Inc., Sanofi S.A.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Pharmaceuticals Market
• Identify segments/areas to invest in over the forecast period in the Global Pharmaceuticals Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. SUMMARY

PART 2. INTRODUCTION

Study period
Geographical scope
Market segmentation

PART 3. PHARMACEUTICALS MARKET OVERVIEW

PART 4. MARKET BREAKDOWN BY PRODUCT

Biologic drugs
Small molecule drugs

PART 5. MARKET BREAKDOWN BY THERAPEUTIC AREA

Antidiabetic drugs
Antirheumatic drugs
Antiviral drugs
Dermatological drugs
Immunosuppressants
Oncology drugs
Vaccines
Others

PART 6. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 7. KEY COMPANIES

AbbVie Inc.
Amgen Inc.
AstraZeneca plc
Bayer AG
Biogen Inc.
Bristol Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche AG
Gilead Sciences, Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co., Inc.
Novartis International AG
Pfizer Inc.
Sanofi S.A.

PART 8. METHODOLOGY